Thanks.
Maybe Ms. Sidhu can explain more about what she meant by this, because my confusion about the motion is that it says:
...the Committee dedicate at least three meetings, by December 2018, to study anti-diabetes strategies in Canada and in other jurisdictions; that, in relation to this study, the Parliamentary Budget Officer provide a cost analysis on the current fiscal impact of diabetes and future projected costs to the Canadian healthcare system...
I hear what Dr. Carrie is saying; that makes sense. I'm unclear about whether the parliamentary budget officer's costing is limited to the current fiscal impact of diabetes or whether Ms. Sidhu wanted the PBO to study the projected costs of anti-diabetes strategies in Canada in the future. That's my first question.
Second, if my reading of it is incorrect and all that is intended is for the PBO to provide a cost analysis of the current fiscal impact of diabetes, then is the part about future projected costs...? Do you mean the future projected costs if we do nothing, or assuming that we have strategies?
What I would find useful as we do this study is to ask the PBO to not only study the current costs of diabetes in our society, but also to cost out, once we know what anti-diabetes strategies might be available to us, what the impact of those might be on the costs.
I'm not sure what Ms. Sidhu meant, and I'd like to know. Maybe we could consider what exactly we want the PBO to cost.